Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Kivu Bioscience Inc.
Hoffmann-La Roche
Aveni Foundation
Bayer
University of California, Irvine
Eastern Cooperative Oncology Group
ViroMissile, Inc.
Karyopharm Therapeutics Inc
Dana-Farber Cancer Institute
Kaiser Permanente
AstraZeneca
University of Florida
Essen Biotech
MacroGenics
Avacta Life Sciences Ltd
Institut Curie
Solve Therapeutics
University of Nebraska
Adela, Inc
Perspective Therapeutics
Ocellaris Pharma, Inc.
M.D. Anderson Cancer Center